Price$120.30+0.75 (+0.63%)
01:30 PM07:45 PM
News · 26 weeks66-67%
2026-04-122026-10-04
Mix2890d
- Insider16(57%)
- SEC Filings5(18%)
- Other4(14%)
- Earnings2(7%)
- Analyst1(4%)
Latest news
25 items- SECAptarGroup Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - APTARGROUP, INC. (0000896622) (Filer)
- PRAptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug DeliveryGoal is to help pharmaceutical innovators evaluate opportunities earlier and accelerate future central nervous system pipelines AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has signed an agreement for a research collaboration led by Alice Stanton, PhD from Massachusetts General Hospital (MGH) to advance the science of nose-to-brain (N2B) drug delivery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914424839/en/Aptar and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Mod
- INSIDERNew insider Ackerman Daniel claimed ownership of 32,779 shares (SEC Form 3)3 - APTARGROUP, INC. (0000896622) (Issuer)
- SECAptarGroup Inc. filed SEC Form 8-K: Leadership Update8-K - APTARGROUP, INC. (0000896622) (Filer)
- INSIDERChief Human Resources Officer Vinczeller Shiela sold $99,733 worth of shares (765 units at $130.37), decreasing direct ownership by 3% to 26,313 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERPresident and CEO Touya Gael was granted 2,637 shares, increasing direct ownership by 9% to 31,739 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- SECAptarGroup Inc. filed SEC Form 8-K: Leadership Update8-K - APTARGROUP, INC. (0000896622) (Filer)
- INSIDERSegment Pres., CEO Designate Touya Gael sold $500,276 worth of shares (3,740 units at $133.76), decreasing direct ownership by 11% to 29,102 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by AptarGroup Inc.SCHEDULE 13G/A - APTARGROUP, INC. (0000896622) (Subject)
- INSIDERSegment President Prieur Marc sold $476,897 worth of shares (3,500 units at $136.26), decreasing direct ownership by 18% to 15,823 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERPresident and CEO Tanda Stephan B. exercised 9,838 shares at a strike of $74.79 and sold $1,339,588 worth of shares (9,838 units at $136.16) (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERSegment President Tlili Hedi sold $1,195,290 worth of shares (8,854 units at $135.00), decreasing direct ownership by 37% to 15,379 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- SECSEC Form 10-Q filed by AptarGroup Inc.10-Q - APTARGROUP, INC. (0000896622) (Filer)
- SECAptarGroup Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - APTARGROUP, INC. (0000896622) (Filer)
- PRAptar Reports Second Quarter 2026 ResultsAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following second quarter results for the period ended June 30, 2026, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260730133160/en/Aptar Reports Second Quarter 2026 Results Second Quarter 2026 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 6% to over $1 billion for the first time, and core sales increa
- PRAptar Beauty Launches Next-Generation Auto-Loading Dropper Technology for Easier, More Accurate Skincare DosingDermalogica Selects Innovative Technology for its FutureCode Skincare Booster AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, announces the first commercial launch of its innovative auto-loading, dosing dropper technology called NeoDropper Autoload. Aptar’s technology is featured on Dermalogica’s FutureCode Booster skincare product. Designed for prestige skincare and dermocosmetic brands, this next-generation dropper packaging is intended to address consumer needs around dosage control, convenience and clean usage by supporting precision dispensing and user experience. This press release features multimed
- INSIDERDirector Fotiades George L was granted 151 shares, increasing direct ownership by 2% to 6,446 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERDirector Kampouri Monnas Giovanna was granted 151 shares, increasing direct ownership by 2% to 10,128 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERDirector Marey-Semper Isabel was granted 151 shares, increasing direct ownership by 2% to 9,821 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERDirector Matthews Candace S. was granted 226 shares, increasing direct ownership by 3% to 8,101 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERDirector Wunderlich Ralf K. was granted 151 shares, increasing direct ownership by 0.81% to 18,690 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERDirector Owens B Craig was granted 151 shares, increasing direct ownership by 1% to 11,234 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERDirector Glickman Sarah Js was granted 151 shares, increasing direct ownership by 3% to 4,553 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERDirector Xing Julie was granted 151 shares, increasing direct ownership by 3% to 5,242 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
- INSIDERDirector Trerotola Matthew L. was granted 151 shares, increasing direct ownership by 2% to 9,307 units (SEC Form 4)4 - APTARGROUP, INC. (0000896622) (Issuer)
ATR FAQ
7 questionsWhat does AptarGroup Inc. do?
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active packaging products...Where does ATR stock trade?
AptarGroup Inc. (ATR) is listed on NYSE.What sector and industry is ATR in?
AptarGroup Inc. operates in the Industrials sector, Plastic Products industry.Does ATR pay a dividend?
ATR's most recent ex-dividend date was 2026-07-30 with a cash dividend of $0.48 per share. No future ex-date is on file yet.What are analysts saying about ATR?
AptarGroup Inc. has had 8 recent analyst actions on file. The most recent action was from BofA Securities: Buy on 2026-07-14.What companies are similar to ATR?
Notable peers in the same industry include ENTG (Entegris Inc.), BERY (Berry Global Group Inc.), AWI (Armstrong World Industries Inc), AZEK (The AZEK Company Inc.), NWL (Newell Brands Inc.). Compare ATR side-by-side with any of them on Quantisnow.How can I track ATR on Quantisnow?
Quantisnow aggregates AptarGroup Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ATR to receive live email and push alerts on every new disclosure.